PTC Therapeutics Q4 Earnings Call Highlights

80% of PKU centers of excellence in the U.S. had written prescriptions for one or more patientsSephience contributed $92 million of revenue in the fourth quarter and $111 million worldwide since launch in 2025. Pauwels said fourth-quarter Sephience revenue was approximately $92 million, including $81 million in the U.S. and $11 million ex-U.S.For the fourth quarter, PTC reported total net product and royalty revenue of $263 million . Full-year 2025 total net product and royalty revenue was $831 million , wh ...